GRAIL, Inc. (GRAL) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US3847471014
GRAIL, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 147.17 m USD |
| Operating income | -562.16 m USD |
| EBIT | -563.16 m USD |
| Net income | -408.35 m USD |
| Diluted EPS – continuing operations | -11.11 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About GRAIL, Inc.
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
More stocks
- Copa Holdings SA (CPA)
- Valmet Oyj (VALMT.HE)
- CICT Mobile Communication Technology Co. Ltd. A (688387.SS)
- 37 Interactive Entertainment Network Technology Group Co Ltd (002555.SZ)
- ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT)
- VARONIS SYSTEMS INC (VRNS)
- Huadian Energy (600726.SS)
- Jiangsu King's Luck Brewery Joint-Stock Co Ltd (603369.SS)
- TELEFLEX INC (TFX)
- Nissin Foods Holdings Co Ltd (2897.T)
- CIRRUS LOGIC, INC. (CRUS)
- RUSH ENTERPRISES INC \TX\ (RUSHA)
Not investment advice. All data without warranty, price as of 20.10.2026. Details in the risk notice.